Literature DB >> 6319471

Increased vascular beta2-adrenoceptor responsiveness in autonomic dysfunction.

D Robertson, A S Hollister, E L Carey, C S Tung, M R Goldberg, R M Robertson.   

Abstract

Responsiveness to the vasopressor, vasodepressor and chronotropic effects of several sympathomimetic amines was assessed in 12 patients with severe autonomic dysfunction and in 8 age-matched control subjects. The patients with autonomic dysfunction showed a profound increase in responsiveness to both isoproterenol and phenylephrine as compared with control subjects. The mean bolus dose of isoproterenol required to increase heart rate by 25 beats/min was 0.9 + 0.2 microgram in the patients and 5.4 + 2.1 micrograms in the control subjects. The dose of isoproterenol required to reduce mean blood pressure by 25 mm Hg was 0.3 + 0.2 and 5.2 + 1.8 micrograms, respectively. Thus, although there is a 6-fold increase in responsiveness to the chronotropic effect of isoproterenol in autonomic dysfunction, the responsiveness to the drug's depressor effect is increased 17-fold. This enhanced depressor sensitivity is quite marked, even with oral beta-adrenoceptor agonists. Beta-adrenoceptor agonists must be used with caution in conditions associated with autonomic dysfunction if dangerous hypotension is to be avoided.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319471     DOI: 10.1016/s0735-1097(84)80264-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

Review 1.  New trends in the treatment of orthostatic hypotension.

Authors:  J Jordan
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Autonomic dysfunction: diagnosis guided by therapy.

Authors:  R M Robertson; I Biaggioni; R Mosqueda-Garcia; D Robertson
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

3.  Effects of cholinergic and beta-adrenergic blockade on orthostatic tolerance in healthy subjects.

Authors:  V A Convertino; T M Sather
Journal:  Clin Auton Res       Date:  2000-12       Impact factor: 4.435

Review 4.  Management of neurogenic orthostatic hypotension in patients with autonomic failure.

Authors:  Christoph Schroeder; Jens Jordan; Horacio Kaufmann
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

Review 5.  Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.

Authors:  Jacquie Baker; Kurt Kimpinski
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

6.  Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.

Authors:  Claudia E Ramirez; Luis E Okamoto; Amy C Arnold; Alfredo Gamboa; André Diedrich; Leena Choi; Satish R Raj; David Robertson; Italo Biaggioni; Cyndya A Shibao
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

7.  Autonomic Blockade Reverses Endothelial Dysfunction in Obesity-Associated Hypertension.

Authors:  Alfredo Gamboa; Rocío Figueroa; Sachin Y Paranjape; Ginnie Farley; Andre Diedrich; Italo Biaggioni
Journal:  Hypertension       Date:  2016-08-15       Impact factor: 10.190

8.  Neck tumour with syncope due to paroxysmal sympathetic withdrawal.

Authors:  J Onrot; R G Wiley; A Fogo; I Biaggioni; D Robertson; A S Hollister
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

9.  Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system.

Authors:  D Robertson; M R Goldberg; C S Tung; A S Hollister; R M Robertson
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

10.  The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache.

Authors:  D Robertson; D W Kincaid; V Haile; R M Robertson
Journal:  Clin Auton Res       Date:  1994-06       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.